FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used to predict the development of progression in the long-term period in patients with squamous cell carcinoma of the head and neck. To do this, determine the degree of involvement in the process of metastasis of regional lymph nodes (X1). In the absence of metastases in the lymph nodes, X1 is estimated at 0 points, and in the presence of metastases in the regional lymph nodes, X1 is estimated at 1 point. Also, the content of actin-binding protein fascin-1 (FSCN1) ng/ml and the content of the enzyme of the signaling system of protein phosphatase 1B (PPM1B) ng/ml are determined by the method of enzyme-linked immunosorbent assay in blood serum. Then the probability of developing progression in the long-term period P is calculated according to the developed formulas. At P≥50%, a high risk is predicted, and at P<50%, a low risk of disease progression is predicted.
EFFECT: method makes it possible to form a risk group of patients with squamous cell carcinoma of the head and neck after complex antitumor treatment for the optimal period of monitoring the progression of the tumor process.
1 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING TUMOUR RESISTANCE TO TETHEGETH THERAPY OF CETUXIMAB IN PATIENTS WITH PLANE-CELLULAR LANGUAGE OF LANGUAGE AND MULTIDISAL BOTTOM OF THE PTA | 2016 |
|
RU2626682C1 |
METHOD OF PREDICTION OF OUTCOMES IN PATIENTS WITH SQUAMOUS CELL CANCER OF THE ORAL MUCOSA | 2023 |
|
RU2802446C2 |
METHOD FOR PREDICTION OF RISK OF HEMATOGENOUS METASTASES IN NON-SMALL-CELL LUNG CANCER PATIENTS AFTER OPERATION | 2019 |
|
RU2733160C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING DISTANT METASTASES IN PATIENTS WITH OPERABLE FORMS OF BREAST CANCER WITH METASTASES IN REGIONAL LYMPH NODES | 2020 |
|
RU2733697C1 |
METHOD FOR PREDICTING THE OUTCOME OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND OROPHARYNX | 2019 |
|
RU2708786C1 |
METHOD OF PREDICTING OUTCOME OF PRE-OPERATIONAL RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK | 2009 |
|
RU2408284C2 |
METHOD OF TREATING LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2020 |
|
RU2739294C1 |
METHOD FOR PREDICTION OF EFFECTIVENESS OF CONSERVATIVE TREATMENT OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2023 |
|
RU2817324C1 |
METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS | 2009 |
|
RU2426991C2 |
METHOD OF COMBINED TREATMENT OF PATIENTS WITH LOCALLY SPREAD RESECTABLE ESOPHAGEAL CANCER | 2009 |
|
RU2419391C1 |
Authors
Dates
2022-01-24—Published
2021-06-28—Filed